Hopfner Robert Lorne's Form 4 filing
Evommune, Inc. (EVMN) · filed Dec 22, 2025
- Accession no.
- 0001012975-25-000937
- Filed
- Dec 22, 2025
- Trade date
- Dec 19, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $17.4K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hopfner Robert LorneCIK 0001551966 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | Common Stock | PPurchaseAcquired | +1,000 | $17.35 | +$17,350 | 4,026 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.